Biotech News
-
Zentek Provides Update on Rumours
March 8, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company…
-
Zentek Welcomes Ravi Kaza to Advisory Board
March 8, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSXV:ZEN)(OTC PINK:ZENYF), a Canadian IP development and commercialization company…
-
Zentek Receives Approval for Nasdaq Listing
March 7, 2022 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and…
-
Hemostemix: Interest Payment on Convertible Debenture
March 3, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Hemostemix Announces $2,750,000 Convertible Debenture
March 2, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased to…
-
Hemostemix Announces Stock Options Grant
March 1, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased…
-
Sixth Wave Innovations Inc. “Green Lixiviant for Gold Mining” Research Program Confirms Non-Toxicity with Superb Gold Recovery
March 1, 2022 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (the “Company” or “Sixth Wave”)…
-
Valeo Pharma Reports Record Annual Revenues for Fiscal 2021
February 28, 2022 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Hemostemix Announces Closing of UNIT Private Placement
February 28, 2022 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) announces that it…
-
Zentek Provides Corporate Update
November 11, 2021 (Source) — Zentek Ltd. (“ZEN” or the “Company”) (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, IP development and…
